GlobeNewswire
PRESS RELEASE June 25, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that its partner Productos Medix, S.A de S.V, (Medix) has provided Saniona with an update on the Mexican regulatory authority Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS)’s ongoing review of tesofensine for the treatment of obesity. According to Medix, as part of the ongoing review process, the tesofensine application was reviewed by